|
Press Releases |
|
 |
|
Tuesday, November 1, 2022 |
|
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round |
Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. more info >> |
|
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round |
Shanghai Easy-Flow ("Easy-Flow") recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow's peripheral intervention pipeline. more info >> |
|
Thursday, October 20, 2022 |
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round |
VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. more info >> |
|
Sunday, September 25, 2022 |
|
GalaxySpace Completes a New Financing Round with Legend Capital Re-upped |
GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. more info >> |
|
Leadrive Technology Completes Series C Financing, Legend Capital Re-upped |
Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing. more info >> |
|
Friday, September 2, 2022 |
|
Legend Capital: The Logic of Technology Investment Has Changed |
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. more info >> |
|
Friday, August 19, 2022 |
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY |
Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. more info >> |
|
Monday, August 15, 2022 |
|
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully |
On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. more info >> |
|
Tuesday, August 9, 2022 |
|
Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully |
On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. more info >> |
|
Monday, August 8, 2022 |
|
New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B |
Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
中旅國際2022年全年綜合收入30.32億港元
Apr 1, 2023 11:58 HKT/SGT
|
|
|
中旅国际2022年全年综合收入30.32亿港元
Apr 1, 2023 11:57 HKT/SGT
|
|
|
China Travel International's Consolidated Revenue of HK$3,032 Million in 2022
Apr 1, 2023 11:56 HKT/SGT
|
|
|
綠地香港2022年收入266.14億,歸母淨利潤4.81億
Apr 1, 2023 11:03 HKT/SGT
|
|
|
绿地香港2022年收入266.14亿,归母净利润4.81亿
Apr 1, 2023 11:02 HKT/SGT
|
|
|
Indonesian MCI Ensures Telecommunication Access for Successful ASEAN Chairmanship 2023
Apr 1, 2023 00:00 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 21:15: JST
|
|
|
中国生物制药(1177.HK)公布2022全年业绩
Mar 31, 2023 21:13 HKT/SGT
|
|
|
中國生物製藥(1177.HK)公佈2022全年業績
Mar 31, 2023 21:12 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results
Mar 31, 2023 21:11 HKT/SGT
|
|
|
Expand Investment in Science and Technology and Empower Industry Development, Legend Holdings Realized Revenue of RMB483.7 billion by 2022
Mar 31, 2023 20:18: JST
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 20:15 HKT/SGT
|
|
|
联控2022年收入4,837亿 稳健经营 蓄力科创
Mar 31, 2023 19:22 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|